Total Funding
50
51
Total FundingPost-IPO Equity raised
Growth Score
-14 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
92157
Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.
- Stephan Jackman: Chief Executive Officer & Director
Ken Cragun: CFOPast Role: Local Corporation, CFO
About the Company
Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease. The company also focused on the facilitation of bringing technologies to market which help with the treatment, prevention, or cure of Alzheimer’s. They providing hope through the commercialization of
existing patented intellectual property while simultaneously funding future treatments through advanced research and development.
Alzamend Neuro was founded in 2016 and is headquartered in Newport Beach, CA, USA.
